Delivery Order SPE2DB20D2104-SPE2DB22FR30J
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,800.37 firm fixed price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- This federal contract award, valued at $1,104.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award, valued at $1,344.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of August 4, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,976.56, is a Firm Fixed Price Delivery Order for the supply of Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of March 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor to various government agencies. The $1,294.51 firm-fixed-price delivery order is for the supply of the medication Junel FE 1 mg-20 mcg tablet, a common birth control product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.35 Firm Fixed Price delivery order is for the supply of JUNEL FE 1.5 MG-30 MCG Tablets 28s, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $1,258.02 firm fixed-price delivery order is for the supply of 4,564,460,292 units of the medication Junel FE 1 mg-20 mcg tablet, with an ultimate completion date of May 2, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical...
- This federal contract award, valued at $1,192.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the pharmaceutical product JUNEL FE 1 MG-20 MCG TABLET 28S. The contract has an ultimate completion date of May 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,166.76 Delivery Order contract is for the supply of the medication Junel FE 1.5 mg-30 mcg tablets in 28-count packages. The contract has a firm fixed price pricing type and runs through September 10, 2024. This award is a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,904.40 for the supply of pharmaceutical products, including the drug Junel FE 1 mg-20 mcg tablet. The contract has an ultimate completion date of April 9, 2025 and utilizes a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR30JDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.06 delivery order is for the supply of the medication Junel FE 1.5 mg-30 mcg tablet, 28s, with a completion date of December 20, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/17/21 |